Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Co-careldopa (Carbidopa/levodopa)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Co-careldopa 10mg/100mg/5ml oral suspension
0409010N0AAAJAJ
|
Co-careldopa | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | No data available |
|
Co-careldopa 10mg/40mg/5ml oral suspension
0409010N0AAAYAY
|
Co-careldopa | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | No data available |
|
Co-careldopa 2.5mg/10mg/5ml oral suspension
0409010N0AAAQAQ
|
Co-careldopa | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | No data available |
|
Co-careldopa 25mg/250mg/5ml oral suspension
0409010N0AAAIAI
|
Co-careldopa | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | No data available |
|
Co-careldopa 5mg/50mg/5ml oral suspension
0409010N0AAAXAX
|
Co-careldopa | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | No data available |
|
Co-careldopa 625microgram/2.5mg/5ml oral suspension
0409010N0AAATAT
|
Co-careldopa | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | No data available |
|
Tilolec 100mg/25mg modified-release tablets
0409010N0BCABAG
|
Tilolec | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | No data available |
|
Tilolec 200mg/50mg modified-release tablets
0409010N0BCAAAE
|
Tilolec | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.